A randomized, open-label study evaluating pharmacokinetics of AXS-05 in healthy volunteers

Trial Profile

A randomized, open-label study evaluating pharmacokinetics of AXS-05 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jan 2016

At a glance

  • Drugs Bupropion/dextromethorphan (Primary)
  • Indications Agitation; Depressive disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jan 2016 New trial record
    • 19 Nov 2015 Results were published in the SEC Form 424B2 for Axsome Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top